Atrium Therapeutics, Inc. Share Price

Atrium Therapeutics, Inc. Share Price

NASDAQ: RNA | Small Cap
$6.47
+$0.04 (0.62%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Atrium Therapeutics, Inc. Stock Performance

Open
$6.89
Prev. Close
$6.43
Circuit Range
N/A
Day Range
$6.45 - $6.94
Year Range
$6.38 - $73.05
Volume
20,892
Average Traded
$6.60

Atrium Therapeutics, Inc. Share Price Today

As of 18 November 2026, Atrium Therapeutics, Inc.'s share price is $6.47. The stock opened at $6.89, compared to its previous close of $6.43. During today's trading session, Atrium Therapeutics, Inc.'s share price traded between $6.45 and $6.94, with an average price of $6.70. Over the past 52 weeks, the stock has recorded a high of $73.05 and a low of $6.38. In terms of performance, Atrium Therapeutics, Inc.'s share price has declined by 50.19% over the last six months and is down 90.98% on a year-on-year basis.

Atrium Therapeutics, Inc. Share Price Chart

Line chart of the Atrium Therapeutics, Inc. price trend over the selected period. The price rose overall, ranging from 6.45 to 6.94, ending at 6.47.
$6.45$6.94
L
Show Current Price
H

Atrium Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$721.94M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.91
Revenue (TTM)
$18.76B
Return On Equity (TTM)
-20.06%
Profit Margin
-3649.41%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
98.20%

Atrium Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.86$19.64$3.00$15.32
Net Profit-$237.10-$16.63-$20.19-$4.27
Net Profit Margin-27569.77%-84.67%-673.00%-27.87%
Income ChangeN/A92.99%-21.41%78.85%

Atrium Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$9.22$9.56$10.90$18.76
Net Profit-$174.00-$212.22-$322.30-$684.63
Net Profit Margin-1887.20%-2219.87%-2956.88%-3649.41%
Income ChangeN/A-21.97%-51.87%-112.42%

About Atrium Therapeutics, Inc.

Atrium Therapeutics Inc is a biopharmaceutical firm focused on developing RNA-based therapeutics for cardiac conditions, including cardiomyopathies. Its platform technology is designed to enable targeted delivery of RNA therapeutics to heart tissue by combining ligand-based targeting approaches with oligonucleotide-based therapies. The company's development pipeline includes programs targeting genetically associated forms of cardiomyopathy, specifically involving the PRKAG2 and PLN genes.

Atrium Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$8.30
$6.45
-22.10%
Oct 2026
$8.37
$8.28
-0.30%
Sep 2026
$13.30
$8.30
-40.34%
Aug 2026
$11.40
$13.92
+22.54%
Jul 2026
$13.42
$11.36
-15.35%
Jun 2026
$12.60
$13.42
+3.31%
May 2026
$13.15
$12.99
+1.80%
Apr 2026
$13.66
$12.76
-4.38%
Mar 2026
$14.13
$13.35
-9.68%
Feb 2026
$72.53
$14.78
-79.64%
Jan 2026
$72.10
$72.57
+0.61%
Dec 2025
$71.49
$72.13
+0.54%

RNA Share Price FAQs